Skip to main content
Erschienen in: Medical Oncology 10/2017

01.10.2017 | Review Article

Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy

verfasst von: Li Li, Ping Tang, Shun Li, Xiang Qin, Hong Yang, Chunhui Wu, Yiyao Liu

Erschienen in: Medical Oncology | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Notch signaling pathway is evolutionarily conserved in mammals, which plays an important role in cell development and differentiation. In recent years, increasing evidence has shown that aberrant activation of Notch is associated with tumor process. Aberrant activation of Notch signaling pathway has been found in many different solid tumors can induce cell proliferation, metastasis and epithelial-mesenchymal transition. Notch receptor and its ligand are both single transmembrane protein, and Notch is activated when it binds to the Notch ligand of neighbor cells. The signal transduction of Notch signaling pathway is only between cells that are in contact with each other, which is independent of second messengers. Thus, Notch needs to cross talk with other signaling pathways, including PI3K/AKT, NF-κB, integrin and miRNAs, to precisely regulate cell fate. In this review, we summarize the roles of Notch signaling pathway in tumor metastasis and its regulatory mechanisms and discuss the current treatment strategies targeting Notch signal pathway.
Literatur
3.
Zurück zum Zitat Andersson M, Olsen JH. Malignant mesotheliomas in Denmark 1943–1980. Cancer statistics 9. Ugeskr Laeger. 1984;146(14):1085–7.PubMed Andersson M, Olsen JH. Malignant mesotheliomas in Denmark 1943–1980. Cancer statistics 9. Ugeskr Laeger. 1984;146(14):1085–7.PubMed
5.
Zurück zum Zitat Danza G, Di Serio C, Ambrosio MR, Sturli N, Lonetto G, Rosati F, et al. Notch3 is activated by chronic hypoxia and contributes to the progression of human prostate cancer. Int J Cancer. 2013;133(11):2577–86. doi:10.1002/ijc.28293.PubMedPubMedCentral Danza G, Di Serio C, Ambrosio MR, Sturli N, Lonetto G, Rosati F, et al. Notch3 is activated by chronic hypoxia and contributes to the progression of human prostate cancer. Int J Cancer. 2013;133(11):2577–86. doi:10.​1002/​ijc.​28293.PubMedPubMedCentral
7.
Zurück zum Zitat Yang Y, Ahn Y-H, Gibbons DL, Zang Y, Lin W, Thilaganathan N, et al. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200—dependent pathway in mice. J Clin Investig. 2011;121(4):1373–85. doi:10.1172/jci42579.CrossRefPubMedPubMedCentral Yang Y, Ahn Y-H, Gibbons DL, Zang Y, Lin W, Thilaganathan N, et al. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200—dependent pathway in mice. J Clin Investig. 2011;121(4):1373–85. doi:10.​1172/​jci42579.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Reedijk M, Odorcic S, Chang L, Zhang H, Miller N, McCready DR, et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 2005;65(18):8530–7. doi:10.1158/0008-5472.CAN-05-1069.CrossRefPubMed Reedijk M, Odorcic S, Chang L, Zhang H, Miller N, McCready DR, et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 2005;65(18):8530–7. doi:10.​1158/​0008-5472.​CAN-05-1069.CrossRefPubMed
10.
Zurück zum Zitat Chance O. Value of statistics in the study of cancer of the uterine cervix. Comptes rendus de la Societe francaise de gynecologie. 1951;21(7):305–11.PubMed Chance O. Value of statistics in the study of cancer of the uterine cervix. Comptes rendus de la Societe francaise de gynecologie. 1951;21(7):305–11.PubMed
11.
Zurück zum Zitat Dotta JS, Delporte TV. Statistics on the treatment of prostatic cancer. Revista argentina de urologia. 1951;20(9–11):255–7.PubMed Dotta JS, Delporte TV. Statistics on the treatment of prostatic cancer. Revista argentina de urologia. 1951;20(9–11):255–7.PubMed
14.
Zurück zum Zitat Cesarani F, Garbagnoli E. Local recurrence and lymphatic and osseous metastases following surgery of breast cancer; radiotherapy department statistics for 1944-50. Athena; rassegna mensile di biologia, clinica e terapia. 1951;17(7–8):189–92.PubMed Cesarani F, Garbagnoli E. Local recurrence and lymphatic and osseous metastases following surgery of breast cancer; radiotherapy department statistics for 1944-50. Athena; rassegna mensile di biologia, clinica e terapia. 1951;17(7–8):189–92.PubMed
16.
Zurück zum Zitat Weinmaster G. Notch signal transduction a real rip and more. Curr Opin Genet Dev. 2000;10:363–9.CrossRefPubMed Weinmaster G. Notch signal transduction a real rip and more. Curr Opin Genet Dev. 2000;10:363–9.CrossRefPubMed
17.
Zurück zum Zitat Nahum AM. Biting the bullet: minimum standards for reporting cancer treatment statistics. Head Neck Surg. 1979;1(3):201.CrossRefPubMed Nahum AM. Biting the bullet: minimum standards for reporting cancer treatment statistics. Head Neck Surg. 1979;1(3):201.CrossRefPubMed
18.
Zurück zum Zitat Upton AC. Survey: reporting practices for cancer treatment statistics. Head Neck Surg. 1979;1(6):500.CrossRef Upton AC. Survey: reporting practices for cancer treatment statistics. Head Neck Surg. 1979;1(6):500.CrossRef
19.
Zurück zum Zitat Ranganathan P, Weaver KL, Capobianco AJ. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer. 2011;11(5):338–51. doi:10.1038/nrc3035.CrossRefPubMed Ranganathan P, Weaver KL, Capobianco AJ. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer. 2011;11(5):338–51. doi:10.​1038/​nrc3035.CrossRefPubMed
20.
Zurück zum Zitat Ellisen LW, Bird J, West PC, et al. TAN+1, the human hormolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastie neoplasms. Cell. 1991;66(4):649–61.CrossRefPubMed Ellisen LW, Bird J, West PC, et al. TAN+1, the human hormolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastie neoplasms. Cell. 1991;66(4):649–61.CrossRefPubMed
21.
Zurück zum Zitat Weng AP, Ferrando AA, Lee W, Morris JP IV, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Thomas Look A, Aster JC. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306(5694):269–71. doi:10.1126/science.1102160.CrossRefPubMed Weng AP, Ferrando AA, Lee W, Morris JP IV, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Thomas Look A, Aster JC. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306(5694):269–71. doi:10.​1126/​science.​1102160.CrossRefPubMed
23.
Zurück zum Zitat Wu F, Stutzman A, Mo YY. Notch signaling and its role in breast cancer. Front Biosci. 2007;12:4370–83.CrossRefPubMed Wu F, Stutzman A, Mo YY. Notch signaling and its role in breast cancer. Front Biosci. 2007;12:4370–83.CrossRefPubMed
25.
28.
Zurück zum Zitat Lefort K, Mandinova A, Ostano P, Kolev V, Calpini V, Kolfschoten I, et al. Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases. Genes Dev. 2007;21(5):562–77. doi:10.1101/gad.1484707.CrossRefPubMedPubMedCentral Lefort K, Mandinova A, Ostano P, Kolev V, Calpini V, Kolfschoten I, et al. Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases. Genes Dev. 2007;21(5):562–77. doi:10.​1101/​gad.​1484707.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Gupta A, Wang Y, Browne C, Kim S, Case T, Paul M, et al. Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells. Prostate. 2008;68(1):50–60. doi:10.1002/pros.20650.CrossRefPubMed Gupta A, Wang Y, Browne C, Kim S, Case T, Paul M, et al. Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells. Prostate. 2008;68(1):50–60. doi:10.​1002/​pros.​20650.CrossRefPubMed
32.
Zurück zum Zitat Parr C, Watkins G, Jiang WG. The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Int J Mol Med. 2004;14(5):779–86.PubMed Parr C, Watkins G, Jiang WG. The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Int J Mol Med. 2004;14(5):779–86.PubMed
33.
Zurück zum Zitat PRESENTATION of results in the treatment of cancer. V. World Health Organization Expert Committee on Health Statistics. Br J Radiol. 1951;24(282):311–314. doi:10.1259/0007-1285-24-282-311. PRESENTATION of results in the treatment of cancer. V. World Health Organization Expert Committee on Health Statistics. Br J Radiol. 1951;24(282):311–314. doi:10.​1259/​0007-1285-24-282-311.
35.
Zurück zum Zitat Li S, Zhang J, Yang H, Wu C, Dang X, Liu Y. Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/Twist-mediated epithelial-mesenchymal transition. Sci Rep. 2015;5:12410. doi:10.1038/srep12410.CrossRefPubMedPubMedCentral Li S, Zhang J, Yang H, Wu C, Dang X, Liu Y. Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/Twist-mediated epithelial-mesenchymal transition. Sci Rep. 2015;5:12410. doi:10.​1038/​srep12410.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Ahmad A, Wang Z, Kong D, Ali R, Ali S, Banerjee S, et al. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-kappaB signaling pathways. Breast Cancer Res Treat. 2011;126(1):15–25. doi:10.1007/s10549-010-0883-2.CrossRefPubMed Ahmad A, Wang Z, Kong D, Ali R, Ali S, Banerjee S, et al. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-kappaB signaling pathways. Breast Cancer Res Treat. 2011;126(1):15–25. doi:10.​1007/​s10549-010-0883-2.CrossRefPubMed
39.
Zurück zum Zitat Xie M, Zhang L, He CS, Xu F, Liu JL, Hu ZH, et al. Activation of Notch-1 enhances epithelial-mesenchymal transition in gefitinib-acquired resistant lung cancer cells. J Cell Biochem. 2012;113(5):1501–13. doi:10.1002/jcb.24019.PubMed Xie M, Zhang L, He CS, Xu F, Liu JL, Hu ZH, et al. Activation of Notch-1 enhances epithelial-mesenchymal transition in gefitinib-acquired resistant lung cancer cells. J Cell Biochem. 2012;113(5):1501–13. doi:10.​1002/​jcb.​24019.PubMed
42.
Zurück zum Zitat Yuan XW, Wang DM, Hu Y, Tang YN, Shi WW, Guo XJ, et al. Hepatocyte nuclear factor 6 suppresses the migration and invasive growth of lung cancer cells through p53 and the inhibition of epithelial-mesenchymal transition. J Biol Chem. 2013;288(43):31206–16. doi:10.1074/jbc.M113.480285.CrossRefPubMedPubMedCentral Yuan XW, Wang DM, Hu Y, Tang YN, Shi WW, Guo XJ, et al. Hepatocyte nuclear factor 6 suppresses the migration and invasive growth of lung cancer cells through p53 and the inhibition of epithelial-mesenchymal transition. J Biol Chem. 2013;288(43):31206–16. doi:10.​1074/​jbc.​M113.​480285.CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science. 1991;251(4996):936–9.CrossRefPubMed Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science. 1991;251(4996):936–9.CrossRefPubMed
47.
Zurück zum Zitat Higashiyama S, Iwamoto R, Goishi K, Raab G, Taniguchi N, Klagsbrun M, et al. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol. 1995;128(5):929–38.CrossRefPubMed Higashiyama S, Iwamoto R, Goishi K, Raab G, Taniguchi N, Klagsbrun M, et al. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol. 1995;128(5):929–38.CrossRefPubMed
49.
Zurück zum Zitat Jezierska A, Motyl T. Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med Sci Monit. 2009;15(2):RA32–40.PubMed Jezierska A, Motyl T. Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med Sci Monit. 2009;15(2):RA32–40.PubMed
54.
Zurück zum Zitat Yamamoto M, Taguchi Y, Ito-Kureha T, Semba K, Yamaguchi N, Inoue J. NF-kappaB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype. Nat Commun. 2013;4:2299. doi:10.1038/ncomms3299.PubMed Yamamoto M, Taguchi Y, Ito-Kureha T, Semba K, Yamaguchi N, Inoue J. NF-kappaB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype. Nat Commun. 2013;4:2299. doi:10.​1038/​ncomms3299.PubMed
56.
57.
Zurück zum Zitat Hales EC, Orr SM, Larson Gedman A, Taub JW, Matherly LH. Notch1 receptor regulates AKT protein activation loop (Thr308) dephosphorylation through modulation of the PP2A phosphatase in phosphatase and tensin homolog (PTEN)-null T-cell acute lymphoblastic leukemia cells. J Biol Chem. 2013;288(31):22836–48. doi:10.1074/jbc.M113.451625.CrossRefPubMedPubMedCentral Hales EC, Orr SM, Larson Gedman A, Taub JW, Matherly LH. Notch1 receptor regulates AKT protein activation loop (Thr308) dephosphorylation through modulation of the PP2A phosphatase in phosphatase and tensin homolog (PTEN)-null T-cell acute lymphoblastic leukemia cells. J Biol Chem. 2013;288(31):22836–48. doi:10.​1074/​jbc.​M113.​451625.CrossRefPubMedPubMedCentral
60.
63.
64.
70.
71.
Zurück zum Zitat Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M, et al. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest. 2007;117(12):3988–4002. doi:10.1172/JCI32533.CrossRefPubMedPubMedCentral Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M, et al. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest. 2007;117(12):3988–4002. doi:10.​1172/​JCI32533.CrossRefPubMedPubMedCentral
73.
Zurück zum Zitat Lee C, Lee C, Lee S, Siu A, Ramos DM. The cytoplasmic extension of the integrin beta6 subunit regulates epithelial-to-mesenchymal transition. Anticancer Res. 2014;34(2):659–64.PubMed Lee C, Lee C, Lee S, Siu A, Ramos DM. The cytoplasmic extension of the integrin beta6 subunit regulates epithelial-to-mesenchymal transition. Anticancer Res. 2014;34(2):659–64.PubMed
75.
76.
Zurück zum Zitat Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9):597–610. doi:10.1038/nrg2843.PubMed Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9):597–610. doi:10.​1038/​nrg2843.PubMed
77.
Zurück zum Zitat Sun DW, Zhang HD, Mao L, Mao CF, Chen W, Cui M, et al. Luteolin inhibits breast cancer development and progression in vitro and in vivo by suppressing Notch signaling and regulating MiRNAs. Cell Physiol Biochem. 2015;37(5):1693–711. doi:10.1159/000438535.CrossRefPubMed Sun DW, Zhang HD, Mao L, Mao CF, Chen W, Cui M, et al. Luteolin inhibits breast cancer development and progression in vitro and in vivo by suppressing Notch signaling and regulating MiRNAs. Cell Physiol Biochem. 2015;37(5):1693–711. doi:10.​1159/​000438535.CrossRefPubMed
80.
81.
Zurück zum Zitat Barbarulo A, Grazioli P, Campese AF, Bellavia D, Di Mario G, Pelullo M, et al. Notch3 and canonical NF-kappaB signaling pathways cooperatively regulate Foxp3 transcription. J Immunol. 2011;186(11):6199–206. doi:10.4049/jimmunol.1002136.CrossRefPubMed Barbarulo A, Grazioli P, Campese AF, Bellavia D, Di Mario G, Pelullo M, et al. Notch3 and canonical NF-kappaB signaling pathways cooperatively regulate Foxp3 transcription. J Immunol. 2011;186(11):6199–206. doi:10.​4049/​jimmunol.​1002136.CrossRefPubMed
82.
Zurück zum Zitat Kumar V, Palermo R, Talora C, Campese AF, Checquolo S, Bellavia D, et al. Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia. Leukemia. 2014;28(12):2324–35. doi:10.1038/leu.2014.133.CrossRefPubMed Kumar V, Palermo R, Talora C, Campese AF, Checquolo S, Bellavia D, et al. Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia. Leukemia. 2014;28(12):2324–35. doi:10.​1038/​leu.​2014.​133.CrossRefPubMed
85.
90.
Zurück zum Zitat Wang XW, Xi XQ, Wu J, Wan YY, Hui HX, Cao XF. MicroRNA-206 attenuates tumor proliferation and migration involving the downregulation of NOTCH3 in colorectal cancer. Oncol Rep. 2015;33(3):1402–10. doi:10.3892/or.2015.3731.CrossRefPubMed Wang XW, Xi XQ, Wu J, Wan YY, Hui HX, Cao XF. MicroRNA-206 attenuates tumor proliferation and migration involving the downregulation of NOTCH3 in colorectal cancer. Oncol Rep. 2015;33(3):1402–10. doi:10.​3892/​or.​2015.​3731.CrossRefPubMed
94.
95.
Zurück zum Zitat Bhagat TD, Zou Y, Huang S, Park J, Palmer MB, Hu C, et al. Notch pathway is activated via genetic and epigenetic alterations and is a therapeutic target in clear cell renal cancer. J Biol Chem. 2017;292(3):837–46. doi:10.1074/jbc.M116.745208.CrossRefPubMed Bhagat TD, Zou Y, Huang S, Park J, Palmer MB, Hu C, et al. Notch pathway is activated via genetic and epigenetic alterations and is a therapeutic target in clear cell renal cancer. J Biol Chem. 2017;292(3):837–46. doi:10.​1074/​jbc.​M116.​745208.CrossRefPubMed
98.
Zurück zum Zitat Knoechel B, Bhatt A, Pan L, Pedamallu CS, Severson E, Gutierrez A, et al. Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the gamma-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case. Cold Spring Harb Mol Case Stud. 2015;1(1):a000539. doi:10.1101/mcs.a000539.CrossRefPubMedPubMedCentral Knoechel B, Bhatt A, Pan L, Pedamallu CS, Severson E, Gutierrez A, et al. Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the gamma-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case. Cold Spring Harb Mol Case Stud. 2015;1(1):a000539. doi:10.​1101/​mcs.​a000539.CrossRefPubMedPubMedCentral
Metadaten
Titel
Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy
verfasst von
Li Li
Ping Tang
Shun Li
Xiang Qin
Hong Yang
Chunhui Wu
Yiyao Liu
Publikationsdatum
01.10.2017
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 10/2017
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-017-1039-6

Weitere Artikel der Ausgabe 10/2017

Medical Oncology 10/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.